Skip to main content

Table 3 Adjusted ORs and 95% CIs for MetS and carotid plaque according to uric acid quartiles

From: Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes

 

ORs (95% CI)

P value for trend

 

Q1

Q2

Q3

Q4

 

MetS

     

Model 1a

1.0

1.42 (0.99-2.04)

2.27 (1.51-3.42)

3.97 (2.58-6.13)

<0.001

Model 2b

1.0

1.37 (0.95-1.98)

2.21 (1.44-3.39)

3.65 (2.33-5.71)

<0.001

Model 3c

1.0

1.33 (0.88-2.07)

2.27 (1.36-3.71)

3.77 (2.26-6.29)

<0.001

Model 4d

1.0

1.22 (0.82-1.83)

1.93 (1.22-3.03)

3.26 (2.03-5.25)

<0.001

carotid plaque

     

Model 1*

1.0

1.33 (0.88-1.89)

1.89 (1.16-2.85)

2.71 (1.62-4.47)

0.013

Model 2†

1.0

1.29 (0.82-1.81)

1.82 (1.13-2.77)

2.53 (1.49-4.13)

0.019

Model 3‡

1.0

1.22 (0.81-1.85)

1.68 (1.12-2.58)

2.42 (1.40-3.75)

0.020

Model 4ξ

1.0

1.18 (0.80-1.76)

1.52 (1.04-2.50)

2.21 (1.32-3.49)

0.036

  1. aModel 1 adjusted for age and gender.
  2. bModel 2 further adjusted for alcohol drinking, smoking, duration of diabetes, and family history of diabetes.
  3. cModel 3 further adjusted for eGFR, CRP, HbA1C and HOMA-IR.
  4. dModel 4 further adjusted for BMI.
  5. *Model 1 adjusted for age and gender.
  6. †Model 2 further adjusted for alcohol drinking, smoking, duration of diabetes, and family history of diabetes.
  7. ‡Model 3 further adjusted for eGFR, CRP, HbA1C and HOMA-IR.
  8. ξModel 4 further adjusted for BMI and MetS.